Enso Ventures

Summary

In 2010 was created Enso Ventures, which is appeared as VC. The fund was located in Europe if to be more exact in United Kingdom. The main department of described VC is located in the London.

The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2017. The higher amount of exits for fund were in 2019. Speaking about the real fund results, this VC is 7 percentage points less often commits exit comparing to other organizations. The typical startup value when the investment from Enso Ventures is 5-10 millions dollars. Opposing the other organizations, this Enso Ventures works on 2 percentage points less the average amount of lead investments. The common things for fund are deals in the range of 5 - 10 millions dollars.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Enso Ventures, startups are often financed by The FSE Group, Novartis Venture Fund, New Enterprise Associates. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, Flagship Pioneering, The FSE Group. In the next rounds fund is usually obtained by Flagship Pioneering, Oxford Capital Partners, Octopus Ventures.

We also calculated 2 valuable employees in our database.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Oil and Gas, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Cellectar Biosciences, NeuroVia, Seres Health.